In summary, we explored novel therapeutic approaches: the PDK‐PDC axis, which is targeting metabolic flexibility, for neurological injury and cognitive impairment caused by cerebral hypoperfusion, and discovered that SG exert mitochondrial protection and anti‐apoptotic activity by selectively targeting PDK2 (Figure9). Here, PDC is linked to Cognitive impairment.